Nucleotide Market Size To Reach $1,377.25 Million By 2030

Nucleotide Market Growth & Trends

The global nucleotide market size is expected to reach USD 1,377.25 million by 2030, registering a CAGR of 7.12% from 2023 to 2030, according to a new report by Grand View Research, Inc. The global nucleotide market is expected to witness substantial growth over the forecast period owing to its widespread use in pharmaceuticals and food & beverage industries. Diagnostic research along with pharmaceutical applications dominated the nucleotide market owning to properties including enhanced immunity, positive effects on the intestines, and positive effects of recovery from stress. In addition, growing R&D in the field of dietary nucleotide coupled with yeast-derived nucleotide for livestock nutrition across the globe is expected to propel demand over the forecast period. 

 Request a free sample copy or view report summary: Nucleotide Market Report

Nucleotide Market Report Highlights

• The TaqMan allelic discrimination segment dominated the global market in 2022, followed by SNP by pyrosequencing

• The diagnostics research segment dominated the global market for nucleotides in 2022

• The deoxy nucleotides (dNTPs) segment dominated the global nucleotide market in 2022 with a revenue share of 47.49% and is furthermore likely to expand with the fastest CAGR of 7.34% over the forecast period

• Asia Pacific is expected to witness the fastest growth among other regions, growing at a CAGR of 7.81% from 2023 to 2030. The presence of the leading nucleotide manufacturer in the region coupled with increasing demand for nutraceuticals and the health food industry is expected to increase demand for the product. In addition, increasing food & beverage additive explorations particularly Asia Pacific is likely to propel market growth for nucleotide over the forecast period

Nucleotide Market Segmentation

Grand View Research has segmented the global nucleotide market report based on product, technology, application, and region

Nucleotide Product Outlook (Revenue, USD Million, 2018 - 2030)

• Deoxy Nucleotides

  • By Production Method

    • Enzyme Sourced

    • Chemical Synthesis

• Dideoxynucleotides

• Nucleotides for RNA Synthesis (rNTP)

• Labelled Nucleotides

Nucleotide Technology Outlook (Revenue, USD Million, 2018 - 2030)

• TaqMan Allelic Discrimination

• Gene Chips & Microarrays

• SNP By Pyrosequencing

• Other

Nucleotide Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceuticals

• Diagnostics Research

• Food & Beverage Additive

• Animal Feed Additive

• Others

Nucleotide Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Nucleotide Market

• CJ CheilJedang Corp.

• Star Lake Bioscience Co., Inc.

• Thermo Fisher Scientific Inc.

• MEIHUA HOLDINGS GROUP CO., LTD.

• F. Hoffmann-La Roche Ltd.

• Biorigin

• DSM Nutritional Products AG

• Promega Corporation

• Agilent Technologies Inc.

• Lallemand Inc.

• Nanjing Biotogether Co., Ltd.

• NuEra Nutraceuticals Inc.

• Ohly